Skip to main content
Log in

Effects of selenium and vitamin E on muscular strength and blood parameters in Steinert disease

  • Original Articles
  • Published:
The Italian Journal of Neurological Sciences Aims and scope Submit manuscript

Abstract

Six patients with Steinert disease were treated with selenium and vitamin E, for a 24 month period, including a first phase of 12 months, 6 months wash-out interval and a second treatment phase of 6 months. Mean segmental strength values showed significant improvement during the first 12 months of therapy, while marked reductions of serum enzymes CPK, SGOT, SGPT and γ-GT were observed in some patients. The results support the hypothesis that selenium may play a role in the development of muscle damage in Steinert disease.

Sommario

Sei pazienti, affetti da malattia di Steinert, sono stati sottoposti a terapia con selenio e vitamina E per un periodo di 24 mesi, che ha incluso una prima fase di 12 mesi, un intervallo di “wash-out” di 6 mesi ed una seconda fase di trattamento di altri 6.

I valori medi di forza segmentaria mostrano un significativo aumento durante i primi 12 mesi di terapia, mentre in alcuni pazienti sono osservabili evidenti riduzioni dei livelli sierici degli enzimi CPK, SGOT, SGPT e γ-GT.

Tali risultati sostengono l'ipotesi che il selenio può rivestire un ruolo nello sviluppo del danno muscolare nella malattia di Steinert.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alevizos B., Spengos M., Vassilopoulos D., Stefanis C.:γ glutamyl transpeptidase: elevated activity in myotonic dystrophy. J. Neurol. Sci. 28:225–231, 1976.

    Article  CAS  PubMed  Google Scholar 

  2. Blackmore D.J., Stanier P.:Methods for the measurement of trace elements in equine blood by electrothermal atomic absorption spectrophotometry. Atomic spectroscopy 5:215, 1984.

    CAS  Google Scholar 

  3. Brooke M.H., Griggs R.C., Mendell J.R., Fenichel G.M., Shumate J.B., Pellegrino R.J.:Clinical trial in Duchenne dystrophy. I: the design of the protocol. Muscle Nerve 4:186–197, 1981.

    Article  CAS  PubMed  Google Scholar 

  4. Bryant S.H.:The physiological basis of myotonia. In: Rowland L.P. (Ed.), Pathogenesis of human muscular dystrophies. Amsterdam-Oxford, Excerpta Medica, 715–728, 1977.

    Google Scholar 

  5. Diplock A.T.:Metabolic functional defects in selenium deficiency. Philos. Trans. R. Soc. Lond. B. 294:105–117, 1981.

    CAS  Google Scholar 

  6. Edwards R.H.T., McDonnel M.:Hand-held dynamometer for evaluating voluntary muscle function. Lancet 2:757, 1974.

    CAS  PubMed  Google Scholar 

  7. Fleming C.R., Lie J.Y., McCall J.T. et al.:Selenium deficiency and fatal cardiomyopathy in a patient on home parenteral nutrition. Gastroenterol. 83:689–693, 1982.

    CAS  Google Scholar 

  8. Gamstorp I., Gustavson K.H., Hellstrom O., Nordgren B.:A trial of selenium and vitamin E in boys with muscular dystrophy.J. Child Neurol. 1/3:211–214, 1986.

    Google Scholar 

  9. Johnson R.A., Baker S.S., Fallon J.T. et al.:An accidental case of cardiomyopathy and selenium deficiency. N. Engl. J. Med. 304:1210–1212, 1981.

    CAS  PubMed  Google Scholar 

  10. Keshan Disease Research Group.Observations on effect of sodium selenite in prevention of Keshan disease. Clin. Med. J. 92:471–476, 1979.

    Google Scholar 

  11. Mansell P.I., Rawlings J., Allison S.P.:Reversal of a skeletal myopathy with selenium supplementation in a patient on home parenteral nutrition. Clin. Nutr. 6/3:179–183, 1987.

    Google Scholar 

  12. Orndahl G., Rindby A., Sein E.:Myotonic dystrophy and selenium. Acta Med. Scand. 211:493–499, 1982.

    CAS  PubMed  Google Scholar 

  13. Orndahl G., Sellden U., Hallin S., Wetterqvist H., Rindby A., Selen E.:Myotonic dystrophy treated with selenium and vitamin E. Acta Med. Scand. 219:407–414, 1986.

    CAS  PubMed  Google Scholar 

  14. Rossi B., Tonelli S., Bargagna P., Siciliano G.:Livelli sierici di selenio nella distrofia miotonica di Steinert. Atti XXIV Congr. Naz. S.I.N., abstract 201, Pisa 10-12 ottobre, 1984.

  15. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., Hoekstra W.G.:Selenium: biochemical role as a component of glutathione peroxidase. Science 179:585–590, 1973.

    Google Scholar 

  16. Schwarz K.:Development and status of experimental work on factor 3-selenium. Fed. Proc. 20:666–669, 1961.

    CAS  PubMed  Google Scholar 

  17. Spiegel M.R.:Statistica. New York, McGraw-Hill, 1976.

    Google Scholar 

  18. Van Ru A.M., Thomson C.D., MCKenzie J.M., Robinson M.F.:Selenium deficiency in total parenteral nutrition. Am. J. Clin. Nutr. 32:2076–2085, 1979.

    Google Scholar 

  19. Witting L.A.:Vitamin E and lipid antioxidants in free-radical-initiated reactions. In: Prior W.A. (Ed.), Free radicals in biology. New York, Academic Press, 295–319, 1980.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rossi, B., Siciliano, G., Risaliti, R. et al. Effects of selenium and vitamin E on muscular strength and blood parameters in Steinert disease. Ital J Neuro Sci 11, 37–42 (1990). https://doi.org/10.1007/BF02334903

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02334903

Key Words

Navigation